MedPath

Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population

Conditions
Osteoporosis
Breast Cancer Female
Interventions
Behavioral: Observational Analysis
Registration Number
NCT04055805
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Studying the current state of the clinical approaches to bone diseases in breast cancer patients treated with adjuvant and/or hormone therapy

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
700
Inclusion Criteria
  • Patients willing to provide the Informed consent to participate to the study
  • Women aged 18-75 years
  • Patients having breast cancer, with no phenotype restrictions
  • Patients in natural and stable menopause
  • Patients having secondary amenorrhea, that arose after the initiation of oncologic treatment, since at least 12 months or 6 months with FSH> 40 U/I
Exclusion Criteria
  • Patients with advanced cancer and/or bone metastases and/or visceral metastases
  • Patients with severe renal insufficiency and/or in dialysis and patients affected by severe endocrine disorders

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Fondazione Policlinico Universitario A. Gemelli RomaObservational AnalysisU.O.C Chirurgia Senologica
Università di Napoli "Federico II"Observational Analysis-
Fondazione Policlinico Universitario A. Gemelli, RomaObservational AnalysisPolo Scienze della Salute della Donna e del Bambino
Università degli Studi di PaviaObservational Analysis-
Università degli Studi di SienaObservational Analysis-
Azienda Ospedaliero-Universitaria Careggi FirenzeObservational Analysis-
Istituto Nazionale dei Tumori di Napoli Fondazione G.PascaleObservational Analysis-
Primary Outcome Measures
NameTimeMethod
Results from some questionnaires related to patients QoL, rated from 1 to 10.26-32 months

Description of the current state of the most frequent clinical and therapeutical approaches to bone diseases in 700 breast cancer menopausal patients treated with adjuvant and/or hormonal therapy. These patients are assessed by questionnaires regarding quality of life, menopausal status and current anti resorptive treatments

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Policlinico Agostino Gemelli

🇮🇹

Roma, RM, Italy

© Copyright 2025. All Rights Reserved by MedPath